Actively Recruiting
Baker Gordon Syndrome Natural History Study
Led by University of Missouri-Columbia · Updated on 2025-08-29
50
Participants Needed
1
Research Sites
105 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The goal of this study is to conduct a prospective, longitudinal assessment of the natural clinical progression of children and adults with Synaptotagmin1-Associated Neurodevelopmental Disorder also known as Baker Gordon Syndrome (BAGOS). This will be performed by acquiring baseline measurements and developing effective outcome measures and diagnostic tools for the disorder, to prepare the healthcare system for future clinical trials.
CONDITIONS
Official Title
Baker Gordon Syndrome Natural History Study
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Genetically confirmed diagnosis of Baker Gordon syndrome
- Age between 0 and 99 years
- Ability to send medical records and diagnostic test results
- Ability to complete tests and questionnaires
- Caregivers or legal representatives over 18 years old
- Legal caregiver of a patient diagnosed with Baker Gordon Syndrome
- Willingness to follow study procedures and sign consent
- Ability to understand study information as assessed by the research team
You will not qualify if you...
- Presence of another condition or co-morbidity unrelated to Baker Gordon syndrome that affects neurodevelopment
- Caregivers or legal representatives under 18 years old
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University of Missouri Columbia
Columbia, Missouri, United States, 65201
Actively Recruiting
Research Team
W
W. David R Arnold, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here